1-6 of 6
Warren Chow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4402: Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era

Garo G. Hagopian, Christopher Grant, Danielle Brazel, Priyanka Kumar, Maki Yamamoto, James Jakowatz, Warren Chow, Thuy Tran, Justin Moyers
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4402.
https://doi.org/10.1158/1538-7445.AM2023-4402
Published: 04 April 2023
View articletitled, Abstract 4402: Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era
Journal Articles

Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma

Keqiang Zhang, Kevin Chu, Xiwei Wu, Hanlin Gao, Jinhui Wang, Yate-Ching Yuan, Sofia Loera, Kimberley Ho, Yafan Wang, Warren Chow, Frank Un, Peiguo Chu, Yun Yen
Journal: Cancer Research
Cancer Res (2013) 73 (4): 1298–1307.
https://doi.org/10.1158/0008-5472.CAN-12-2086
Published: 14 February 2013
View articletitled, Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma
Open the PDF for Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract 2609: Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6

Min Guan, Chunling Jiang, Kristen N. Fousek, Song Guo, Warren Chow
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2609.
https://doi.org/10.1158/1538-7445.AM10-2609
Published: 15 April 2010
View articletitled, Abstract 2609: Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6
Journal Articles

A randomized phase II neoadjuvant trial in patients with stages II-III and inflammatory breast cancer.

George Somlo, Benjamin Paz, Jeannie Shen, Carlos Garberoglio, Thehang Luu, Paul Frankel, Norma Baker, Sharon Wilczynski, Richard Jove, Janni Mirosevich, Arti Hurria, Warren Chow, Lawrence Wagman, Jana Portnow, Sally Shaw, Lalit Vora, Richard Pezner, Kim Arnold, Chris Ruel, Yun Yen
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3515.
Published: 01 May 2007
View articletitled, A randomized phase II neoadjuvant trial in patients with stages II-III and inflammatory breast cancer.
Journal Articles

Nelfinavir-induced liposarcoma apoptosis is mediated by TNF-α/TNF-R1

Min Guan, Song Guo, Warren Chow
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1472.
Published: 01 May 2007
View articletitled, Nelfinavir-induced liposarcoma apoptosis is mediated by TNF-α/TNF-R1
Journal Articles

Phase I Trial of Intraperitoneal Iododeoxyuridine with and without Intravenous High-Dose Folinic Acid in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: Flow Cytometric and Pharmacokinetic Analysis

Robert J. Morgan, Jr., Edward M. Newman, James H. Doroshow, Kathryn McGonigle, Kim Margolin, James Raschko, Warren Chow, George Somlo, Lucille Leong, Merry Tetef, Stephen Shibata, Victor Hamasaki, Mary Carroll, Steven Vasilev, Steven Akman, Paul Coluzzi, Lawrence Wagman, Jeff Longmate, Benjamin Paz, Yun Yen, Robert Klevecz
Journal: Cancer Research
Cancer Res (1998) 58 (13): 2793–2800.
Published: 01 July 1998
View articletitled, Phase I Trial of Intraperitoneal Iododeoxyuridine with and without Intravenous High-Dose Folinic Acid in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: Flow Cytometric and Pharmacokinetic Analysis
Open the PDF for Phase I Trial of Intraperitoneal Iododeoxyuridine with and without Intravenous High-Dose Folinic Acid in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: Flow Cytometric and Pharmacokinetic Analysis in another window